{
    "title": "AstraZeneca heart drug gets preferred status in U.S.",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2782169/AstraZeneca-heart-drug-gets-preferred-status-U-S.html",
    "date": "2014-10-06",
    "keywords": [
        "drug",
        "heart",
        "status",
        "october",
        "brilinta",
        "plavix",
        "cardiology",
        "year",
        "gmt",
        "email",
        "london",
        "clopidogrelthe",
        "endorsement",
        "guideline",
        "association",
        "college",
        "management",
        "nonstelevation",
        "acute",
        "chest",
        "pain",
        "electrocardiogram",
        "changesastrazeneca",
        "monday",
        "time",
        "type",
        "treatment",
        "syndromesbrilinta",
        "traction",
        "market",
        "sanofi",
        "generichowever",
        "august",
        "department",
        "justice",
        "investigation",
        "trial",
        "marketing",
        "approval",
        "shadow",
        "hanging",
        "productastrazeneca",
        "promise",
        "defence",
        "takeover",
        "bid",
        "pfizer",
        "number",
        "variety",
        "indication",
        "series",
        "way",
        "case",
        "pegasus",
        "vice",
        "president",
        "tom",
        "roach",
        "example",
        "momentum",
        "brand",
        "line",
        "end",
        "reporting",
        "ben",
        "hirschler",
        "editing",
        "mark",
        "potter"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}